HIV I & II BY CMIA
@ Uniclinic, Kolkata

The HIV I and II CMIA (Chemiluminescent Microparticle Immunoassay) blood test is utilized to distinguish the presence of antibodies to the Human Immunodeficiency Infection (HIV), which causes Helps. This test explicitly searches for antibodies to HIV types 1 and 2.

Reason:

HIV Screening : The main role of the test is to evaluate people for HIV disease, particularly those in danger or with likely openness.

Diagnosis : It supports the determination of HIV, taking into account ideal treatment and the executives of the contamination.

Testing Method:

1. Sample Collection : A blood test is drawn, normally from a vein in the arm.

2. Laboratory Analysis : The example is tried utilizing the CMIA strategy, which includes blending the blood test with explicit HIV antigens. Assuming antibodies are available, a response happens, delivering a sign that can be estimated.

Translation of Results:

Positive Result : A positive outcome demonstrates that HIV antibodies are available, proposing that the individual might be contaminated with HIV. Corroborative testing, (for example, a HIV viral burden test or a HIV Western smear test) is normally expected to affirm the conclusion.

Negative Result : An adverse outcome demonstrates that no antibodies were identified. Be that as it may, it is vital to consider the "window period," which is the time between openness to the infection and the development of perceivable antibodies. Now and again, follow up testing might be suggested assuming that new openness is thought.

Clinical Use:

The HIV I and II CMIA test is generally utilized in medical care settings for routine screening, especially in populaces at higher gamble for HIV. Early location is pivotal for the viable administration and treatment of HIV, decreasing the gamble of transmission and working on tolerant results.

In the event that you have any further inquiries or need extra data about the HIV I and II CMIA test, go ahead and inquire!